DK1276476T3 - Anvendelse af bradykardiske midler ved behandling af sygdomme i hjertemuskulaturen i forbindelse med hypertrofi, samt hedtil ukendte lægemiddelkombinationer - Google Patents

Anvendelse af bradykardiske midler ved behandling af sygdomme i hjertemuskulaturen i forbindelse med hypertrofi, samt hedtil ukendte lægemiddelkombinationer

Info

Publication number
DK1276476T3
DK1276476T3 DK01949281T DK01949281T DK1276476T3 DK 1276476 T3 DK1276476 T3 DK 1276476T3 DK 01949281 T DK01949281 T DK 01949281T DK 01949281 T DK01949281 T DK 01949281T DK 1276476 T3 DK1276476 T3 DK 1276476T3
Authority
DK
Denmark
Prior art keywords
hypertrophy
treatment
well
diseases associated
cardiovascular diseases
Prior art date
Application number
DK01949281T
Other languages
English (en)
Inventor
Brian Guth
Juergen Daemmgen
Randolph Seidler
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1276476T3 publication Critical patent/DK1276476T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK01949281T 2000-04-13 2001-04-07 Anvendelse af bradykardiske midler ved behandling af sygdomme i hjertemuskulaturen i forbindelse med hypertrofi, samt hedtil ukendte lægemiddelkombinationer DK1276476T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10018401A DE10018401A1 (de) 2000-04-13 2000-04-13 Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen

Publications (1)

Publication Number Publication Date
DK1276476T3 true DK1276476T3 (da) 2006-08-14

Family

ID=7638652

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01949281T DK1276476T3 (da) 2000-04-13 2001-04-07 Anvendelse af bradykardiske midler ved behandling af sygdomme i hjertemuskulaturen i forbindelse med hypertrofi, samt hedtil ukendte lægemiddelkombinationer

Country Status (33)

Country Link
US (2) US7208508B2 (da)
EP (2) EP1666042A3 (da)
JP (1) JP3905386B2 (da)
KR (1) KR20020089453A (da)
CN (1) CN1245963C (da)
AT (1) ATE330588T1 (da)
AU (2) AU7048401A (da)
BG (1) BG65816B1 (da)
BR (1) BR0109996A (da)
CA (2) CA2404120C (da)
CY (1) CY1105081T1 (da)
CZ (1) CZ300549B6 (da)
DE (2) DE10018401A1 (da)
DK (1) DK1276476T3 (da)
EA (1) EA006977B1 (da)
EE (1) EE05099B1 (da)
ES (1) ES2266216T3 (da)
HR (1) HRP20020815A2 (da)
HU (1) HU228387B1 (da)
IL (2) IL152103A0 (da)
ME (1) MEP45908A (da)
MX (1) MXPA02009935A (da)
NO (1) NO330311B1 (da)
NZ (1) NZ521934A (da)
PL (1) PL215235B1 (da)
PT (1) PT1276476E (da)
RS (1) RS51478B (da)
SI (1) SI1276476T1 (da)
SK (1) SK286075B6 (da)
TR (1) TR200202326T2 (da)
UA (1) UA78679C2 (da)
WO (1) WO2001078699A2 (da)
ZA (1) ZA200208162B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10018401A1 (de) 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
US20040138306A1 (en) * 2002-07-25 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
DE60200160T2 (de) * 2002-07-25 2004-11-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Cilobradine oder pharmazeutisch akzeptablen Salze zur Behandlung oder Prävention von Herzversagen
JP3874419B2 (ja) * 2003-01-31 2007-01-31 三共株式会社 動脈硬化及び高血圧症の予防及び治療のための医薬
WO2007001066A1 (en) * 2005-06-27 2007-01-04 Daiichi Sankyo Company, Limited Pharmaceutical preparation containing an angiotensin ii receptor antagonist and a calcium channel blocker
JPWO2007023775A1 (ja) * 2005-08-23 2009-02-26 アステラス製薬株式会社 心房細動治療剤
EP1762179A1 (en) * 2005-09-07 2007-03-14 Boehringer Ingelheim Vetmedica Gmbh Method for improving diagnostic quality in echocardiography
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
TWI399223B (zh) * 2006-09-15 2013-06-21 Daiichi Sankyo Co Ltd 奧美沙坦酯及氨氯地平之固體劑型
EP1908469A1 (en) 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
AU2010251194B2 (en) 2009-05-20 2016-02-25 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical oral telmisartan solution
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
KR101296743B1 (ko) * 2011-02-17 2013-08-20 한국과학기술연구원 심근 비대증 진단용 바이오마커 및 이를 이용한 심근 비대증 진단 방법
KR20140057604A (ko) 2011-08-12 2014-05-13 베링거잉겔하임베트메디카게엠베하 고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제
WO2014122248A1 (en) 2013-02-11 2014-08-14 Boehringer Ingelheim Vetmedica Gmbh Kit-of-parts
NZ759782A (en) 2017-07-07 2023-06-30 Boehringer Ingelheim Vetmedica Gmbh Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in cats
EP3996709A1 (en) 2019-07-09 2022-05-18 Boehringer Ingelheim Vetmedica GmbH Telmisartan for the treatment of hypertension in dogs
KR102398532B1 (ko) 2020-07-20 2022-05-13 한림대학교 산학협력단 중증 지주막하출혈 진단용 조성물
KR102331806B1 (ko) 2020-07-20 2021-12-01 한림대학교 산학협력단 중증 지주막하출혈 진단용 바이오 마커

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759125A (fr) 1969-11-19 1971-05-18 Boehringer Sohn Ingelheim Nouvelles n-allyl-2-arylamino-imidazolines-(2) substituees et procedes pour les fabriquer
DE3119874A1 (de) 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
US5175157A (en) * 1985-11-27 1992-12-29 Boehringer Ingelheim Gmbh Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them
DE3541811A1 (de) * 1985-11-27 1987-06-04 Thomae Gmbh Dr K Neue cyclische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3736866A1 (de) * 1987-10-30 1989-05-11 Thomae Gmbh Dr K Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
DE3805635A1 (de) 1988-02-24 1989-09-07 Thomae Gmbh Dr K Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica
US5308853A (en) * 1991-12-20 1994-05-03 Warner-Lambert Company Substituted-5-methylidene hydantoins with AT1 receptor antagonist properties
RU2078536C1 (ru) * 1993-09-02 1997-05-10 Украинский научно-исследовательский институт кардиологии им.акад.Н.Д.Стражеско Способ определения клинической эффективности применения верапамила и дилтиазема у больных гипертрофической кардиомиопатией
CZ86796A3 (en) * 1993-09-24 1996-10-16 Procter & Gamble Novel deoxy and on oxygen substituted sugar derivatives of aminosteroidal compounds
US5595987A (en) * 1994-07-22 1997-01-21 The Trustees Of Columbia University In The City Of New York Method of slowing ventricular arrhythmias using zatebradine
US6083991A (en) * 1997-06-04 2000-07-04 University Of Florida Research Foundation, Inc. Anti-arrhythmic composition and methods of treatment
DE19741635A1 (de) * 1997-09-22 1999-03-25 Hoechst Marion Roussel De Gmbh Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
KR20040078140A (ko) 1998-07-10 2004-09-08 노파르티스 아게 발사르탄 및 칼슘 채널 차단제의 항고혈압 병용 제제
DE10018401A1 (de) * 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
US20040138306A1 (en) * 2002-07-25 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
CA2435526A1 (en) 2002-07-25 2004-01-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of cyclic amine derivatives or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
EP1762179A1 (en) * 2005-09-07 2007-03-14 Boehringer Ingelheim Vetmedica Gmbh Method for improving diagnostic quality in echocardiography

Also Published As

Publication number Publication date
NO20024924L (no) 2002-10-11
ATE330588T1 (de) 2006-07-15
NZ521934A (en) 2007-05-31
US20070155679A1 (en) 2007-07-05
JP3905386B2 (ja) 2007-04-18
SK14582002A3 (sk) 2003-03-04
JP2003535050A (ja) 2003-11-25
EA006977B1 (ru) 2006-06-30
WO2001078699A2 (de) 2001-10-25
PL215235B1 (pl) 2013-11-29
DE10018401A1 (de) 2001-10-25
EA200201053A1 (ru) 2003-02-27
IL152103A (en) 2008-07-08
SI1276476T1 (sl) 2006-10-31
NO20024924D0 (no) 2002-10-11
PT1276476E (pt) 2006-09-29
DE50110262D1 (de) 2006-08-03
US7208508B2 (en) 2007-04-24
ES2266216T3 (es) 2007-03-01
PL357827A1 (en) 2004-07-26
BG107103A (bg) 2003-04-30
BG65816B1 (bg) 2010-01-29
UA78679C2 (en) 2007-04-25
NO330311B1 (no) 2011-03-28
KR20020089453A (ko) 2002-11-29
BR0109996A (pt) 2003-05-27
TR200202326T2 (tr) 2003-03-21
MEP45908A (en) 2011-02-10
YU76902A (sh) 2006-05-25
CZ20023752A3 (cs) 2003-03-12
EP1276476A2 (de) 2003-01-22
RS51478B (sr) 2011-04-30
HUP0300917A2 (hu) 2003-08-28
CA2575059A1 (en) 2001-10-25
AU7048401A (en) 2001-10-30
EP1666042A2 (de) 2006-06-07
MXPA02009935A (es) 2003-02-12
HUP0300917A3 (en) 2009-04-28
AU2001270484B2 (en) 2007-01-25
EE200200590A (et) 2004-04-15
CN1245963C (zh) 2006-03-22
EP1666042A3 (de) 2006-06-21
CN1422153A (zh) 2003-06-04
CA2404120A1 (en) 2001-10-25
HU228387B1 (en) 2013-03-28
HRP20020815A2 (en) 2004-12-31
EP1276476B1 (de) 2006-06-21
CY1105081T1 (el) 2009-11-04
IL152103A0 (en) 2003-07-31
SK286075B6 (sk) 2008-03-05
EE05099B1 (et) 2008-12-15
US20040014795A1 (en) 2004-01-22
ZA200208162B (en) 2003-10-17
WO2001078699A3 (de) 2002-06-20
CA2404120C (en) 2008-01-22
CZ300549B6 (cs) 2009-06-10

Similar Documents

Publication Publication Date Title
EE200300544A (et) 4-anilinokinoliin-3-karboksamiidid, nende kasutamine ning valmistamine
DK1620437T3 (da) 5,7-diaminopyrazolo-4,3-d-pyrimidiner, der er anvendelige til behandling af hypertension
EE200200704A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
AR028240A1 (es) Un articulo absorbente desechable, presujetado y el proceso para hacer dicho articulo
EE200200470A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
DE60131971D1 (de) 1,3,8-TRIAZA-SPIROi4,5 DECAN-4-ONDERIVATIVE ALS NEUROKININREZEPTORANTAGONISTEN
DK1373256T3 (da) CCR5-antagonister, der er nyttige til behandling af AIDS
AR027945A1 (es) Uso de pramipexol en el tratamiento de transtornos de adiccion
ATE541843T1 (de) 2-acylamino-4-phenylthiazolderivate, ihre herstellung und anwendung als chemokin antagonisten
DE60015004D1 (de) Russ, seine Herstellung und Verwendungen
EE200300400A (et) Pürimidiiniühendid, nende valmistamismeetod ning kasutamine
ATE393614T1 (de) Enganliegende, flüssigkeitsaustritt- widerstandsfähige damenbinde
NO20034864L (no) Preparat for behandling av legemiddelindusert forstoppelse med 15-keto-prostaglandiner
BR0208971B1 (pt) produto absorvente com ajuste melhorado.
BR0208970B1 (pt) produto absorvente com ajuste melhorado.
BR0106411B1 (pt) processo de tratamento do lìquido residual de cromatização.
BR0208969B1 (pt) produto absorvente com ajuste melhorado.
SI1276476T1 (sl) Uporaba bradikardnih snovi pri zdravljenju miokardnih bolezni, povezanih s hipertrofijo, in nove kombinacije zdravil
DK1245613T3 (da) Fremgangsmåde til fremstilling af tannin samt dets anvendelse
EE200200697A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
ATE427938T1 (de) Herstellung von dibenzoab,fuazepine zwischenprodukte
HRP20090513T1 (hr) S-mirtazapin, namijenjen liječenju napadaja vrućine
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
DK1461042T3 (da) Anvendelse af desoxypeganin til behandling af klinisk depression
DE60124516D1 (de) Kombination des lezithins mit ascorbinsäure